BRD2 and neoplasm: Pathological reviews categorized by immunohistochemistry staining showed GH producing pituitary tumor as the most prevalent result at 55.2%, followed by GH with PRL co-producing tumor at 26.4%, and GH + PRL + FSH/LH producing tumor at 18.4%.